Literature DB >> 7598712

Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM).

A Hamann1, C Mantzoros, A Vidal-Puig, J S Flier.   

Abstract

Recent evidence suggests that expression of tumor necrosis factor-alpha (TNF-alpha) by adipocytes is a molecular mediator of insulin resistance in obesity. We have therefore tested the hypothesis that variations within the regulatory region of the TNF-alpha gene, which might cause increased adipocyte or generalized TNF-alpha synthesis, are associated with NIDDM, a state in which insulin resistance is routinely observed. Neither the previously known variants within the TNF-alpha promoter at position -308 and -238, nor two newly identified polymorphisms at position -376 and -163, were found at a significantly higher frequency in Caucasian NIDDM patients compared to non-diabetic controls. No genetic variants were found in Pima Indians. These data make it unlikely that mutations within regulatory elements of the TNF-alpha gene are associated with an increase in the prevalence of NIDDM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598712     DOI: 10.1006/bbrc.1995.1887

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

Review 1.  Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis.

Authors:  C L Verweij
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

Review 3.  Host genetic factors in susceptibility to HIV-1 infection and progression to AIDS.

Authors:  Koushik Chatterjee
Journal:  J Genet       Date:  2010-04       Impact factor: 1.166

4.  Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes.

Authors:  S J Hasstedt; M Hoffman; M F Leppert; S C Elbein
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  TNF A -308G>A polymorphism in Moroccan patients with type 2 diabetes mellitus: a case-control study and meta-analysis.

Authors:  Hajar Sefri; Houda Benrahma; Hicham Charoute; Fouzia Lakbakbi el Yaagoubi; Hassan Rouba; Badiaa Lyoussi; Jalal Nourlil; Omar Abidi; Abdelhamid Barakat
Journal:  Mol Biol Rep       Date:  2014-06-22       Impact factor: 2.316

6.  Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis.

Authors:  E L Kaijzel; M V van Krugten; B M Brinkman; T W Huizinga; T van der Straaten; J M Hazes; H W Ziegler-Heitbrock; S A Nedospasov; F C Breedveld; C L Verweij
Journal:  Mol Med       Date:  1998-11       Impact factor: 6.354

7.  Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter.

Authors:  A M Uglialoro; D Turbay; P A Pesavento; J C Delgado; F E McKenzie; J G Gribben; D Hartl; E J Yunis; A E Goldfeld
Journal:  Tissue Antigens       Date:  1998-10

8.  Rapid genotyping of tumor necrosis factor alpha with fluorogenic hybridization probes on the LightCycler.

Authors:  Naoko Hayashi; Yu Imamura; Yukiharu Hiyoshi; Hiroshi Takamori; Toru Beppu; Masahiko Hirota; Hideo Baba
Journal:  Clin Exp Med       Date:  2008-09-25       Impact factor: 3.984

9.  Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population.

Authors:  Deepali Gambhir; Able Lawrence; Amita Aggarwal; Ramnath Misra; Sudhir Kumar Mandal; Sita Naik
Journal:  Rheumatol Int       Date:  2009-09-25       Impact factor: 2.631

10.  Allele-specific quantification of TNFA transcripts in rheumatoid arthritis.

Authors:  B M Brinkman; T W Huizinga; F C Breedveld; C L Verweij
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.